The treatment of hematologic malignancies with single or double umbilical cord blood unit transplantation followed by graft-versus-host prophylaxis with tacrolimus and mycophenolate mofetil.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antithymocyte globulin; Cyclophosphamide; Filgrastim; Filgrastim; Fludarabine; Methylprednisolone; Mycophenolate mofetil; Mycophenolate mofetil; Tacrolimus; Tacrolimus
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Adverse reactions
Most Recent Events
- 20 May 2014 Biomarkers information updated
- 14 May 2012 Actual patient number changed from 7 to 6 as reported by ClinicalTrials.gov.
- 14 May 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.